Clean over-the-counter medicine company Genexa has been granted a patent for its drinkable agave-based medicines containing acetaminophen. This is significant because the brand uses the same effective active ingredients as category leaders in the OTC medicine space but without any of the artificial inactive ingredients, artificial sweeteners, dyes or common allergens. And as Genexa shared in a press release, "Artificial fillers typically comprise more than half of what is ingested each time traditional medicines are used."
With the acceptance of its first parent, the company is pioneering a new direction for clean medicine. This new patent is most applicable to the company's Infants’ Pain & Fever and Kids’ Pain & Fever products, which will suit parents who want to invest in products that deliver results in a safe way without extraneous ingredients.
Agave-Based Medicines
Genexa Was Granted a Patent for Its Drinkable Agave-Based Medicines
Trend Themes
1. Clean Medicine - Genexa's drinkable agave-based medicines are disrupting the traditional OTC medicine space by offering clean medicine without artificial inactive ingredients.
2. Plant-based Medicines - Genexa's use of agave in their medicine is part of a larger trend towards plant-based alternatives in healthcare.
3. Natural Pain Relief - Genexa's patent for their Infants’ Pain & Fever and Kids’ Pain & Fever products is part of a trend towards natural pain relief for children.
Industry Implications
1. Pharmaceuticals - The pharmaceutical industry can benefit from exploring and investing in clean, plant-based medicines like Genexa's agave-based products.
2. Health & Wellness - The health and wellness industry can take advantage of the trend towards natural pain relief by promoting and selling products like Genexa's clean medicine options.
3. Parenting - Parents who are invested in natural and clean products for their children can benefit from the disruptive innovation of Genexa's agave-based pain and fever relievers.